Preclinical candidate criteria within the DDU/WCAIR

University of Dundee Nid oedd gan y wybodaeth y gofynnwyd amdani.

S. Grove (Ataliwyd y cyfrif)

Dear University of Dundee,

Which GlaxoSmithKline (GSK) process chemistry department supplied the API anticipated cost of goods assessment for the visceral leishmaniasis candidate DDD853651/GSK3186899 prior to it's nomination as a preclinical development candidate by the University of Dundee.

When did the process chemistry department at GSK supply their API anticipated cost of goods assessment to The University of Dundee?

What was the generic cost of goods criteria for preclinical development candidates within the leishmaniasis and/or chagas disease and/or neglected disease therapeutic areas within the Drug Discovery Unit (DDU) or Wellcome Centre for Anti-Infectives Research (WCAIR) at the time that DDD853651/GSK3186899 was nominated as a preclinical candidate (either API anticipated COG and/or cost in terms of anticipated $/treatment and/or $/day and/or any other metric that the DDU/WCAIR use)?

What was the GSK-reported API anticipated cost of goods assessment for DDD853651/GSK3186899 at the time of candidate nomination to the status of preclinical development candidate by the DDU/WCAIR?

Yours faithfully,
S. Grove

FreedomOfInformation, University of Dundee

Thank you for your email.  If your message contains a request for
information the University will respond no later than 20 working days from
its receipt (or one month from receipt in the case of requests for your
own personal information).

If you have any questions about how your request will be managed, please
let me know.

Kind regards,

Alan Bell

Head of Information Governance

University of Dundee

Dundee DD1 4HN

The University of Dundee is a registered Scottish Charity, No: SC015096

FreedomOfInformation, University of Dundee

Dear S. Grove,

Thank you for your request for information from the University of Dundee. Colleagues confirm that the University does not hold the costing information you request. Please treat this email as notice of that per S.17 of FoI(S)A.

Colleagues suggest that you may find the Target Product Profiles published by Drugs for Neglected Diseases initiative (DNDi) useful. They are available online here - https://www.dndi.org/diseases-projects/t....

I trust that this is helpful.

Kind regards,

Alan

--
Alan Bell
Head of Information Governance
Culture & Information
University of Dundee
Dundee DD1 4HN

t: 01382 384441
http://www.dundee.ac.uk/cultureandinform...

This email is not legal advice and should not be
considered in that way.

Should you wish to appeal any decision concerning
the release of information by the University please
respond to [University of Dundee request email].
The University will then review your appeal according
to the procedures at
http://www.dundee.ac.uk/information-gove...
If you are unhappy with the outcome of that review please forward your appeal to the Scottish Information Commissioner, Kinburn Castle, Doubledykes Rd, St Andrews, Fife, KY16 9DS (www.itspublicknowledge.info/Appeal).

If you remain dissatisfied following an appeal to the Commissioner your recourse is to the Court of Session on a point of law.

dangos adrannau a ddyfynnir

Dear University of Dundee,

Which GlaxoSmithKline (GSK) process chemistry department supplied the API anticipated cost of goods assessment for the visceral leishmaniasis candidate DDD853651/GSK3186899 prior to it's nomination as a preclinical development candidate by the University of Dundee.

When did the process chemistry department at GSK supply their API anticipated cost of goods assessment to The University of Dundee?

What was the generic cost of goods criteria for preclinical development candidates within the leishmaniasis and/or chagas disease and/or neglected disease therapeutic areas within the Drug Discovery Unit (DDU) or Wellcome Centre for Anti-Infectives Research (WCAIR) at the time that DDD853651/GSK3186899 was nominated as a preclinical candidate (either API anticipated COG and/or cost in terms of anticipated $/treatment and/or $/day and/or any other metric that the DDU/WCAIR use)?

What was the GSK-reported API anticipated cost of goods assessment for DDD853651/GSK3186899 at the time of candidate nomination to the status of preclinical development candidate by the DDU/WCAIR?

Yours faithfully,
S. Grove

-------------------------------------------------------------------

Please use this email address for all replies to this request:
[FOI #513315 email]

Is [University of Dundee request email] the wrong address for Freedom of Information requests to University of Dundee? If so, please contact us using this form:
https://www.whatdotheyknow.com/change_re...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://www.whatdotheyknow.com/help/offi...

For more detailed guidance on safely disclosing information, read the latest advice from the ICO:
https://www.whatdotheyknow.com/help/ico-...

Please note that in some cases publication of requests and responses will be delayed.

If you find this service useful as an FOI officer, please ask your web manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------

The University of Dundee is a registered Scottish Charity, No: SC015096